THE ABC SUBTYPE OF DIFFUSE LARGE B-CELL LYMPHOMA IS RESPONSIVE TO IBRUTINIB

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2015年 / 5卷 / 09期
关键词：
D O I：
10.1158/2159-8290.CD-RW2015-141
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：904 / 904
页数：1
相关论文
共 50 条
  • [31] Cutaneous diffuse large B-cell lymphoma, leg type, secondary to testicular diffuse large B-cell lymphoma
    Pampin, A.
    Gomez-de la Fuente, E.
    Feltes, R. A.
    Pinedo, F.
    Rodriguez-Peralto, J. L.
    Lopez-Estebaranz, J. L.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2014, 39 (02) : 230 - 232
  • [32] Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma
    Zhang, Xiao-tuan
    Hu, Xiao-bei
    Wang, Han-lin
    Kan, Wei-juan
    Xu, Lei
    Wang, Zhi-jia
    Xiang, Yu-qi
    Wu, Wen-biao
    Feng, Bo
    Li, Jia-nan
    Gao, An-hui
    Dong, Tian-cheng
    Xia, Chun-mei
    Zhou, Yu-bo
    Li, Jia
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (05) : 814 - 823
  • [33] Mutation Impact of Targeted Genes in Diffuse Large B-Cell Lymphoma Patients Treated with Ibrutinib
    Cheung, Leo W. K.
    Schweighofer, Karl J.
    Wu, Shiquan
    Kuo, Hsu-Ping
    Eckert, Karl
    Balasubramanian, Sriram
    Ricci, Deborah
    Liang, Yu
    Beaupre, Darrin
    Chang, Betty Y.
    BLOOD, 2015, 126 (23)
  • [34] Targeting PI3 pathway in ibrutinib resistant diffuse large B-cell lymphoma
    Sehgal, Lalit
    Shuttleworth, Stephen Joseph
    Samaniego, Felipe
    CANCER RESEARCH, 2017, 77
  • [35] PDGFD induces ibrutinib resistance of diffuse large B-cell lymphoma through activation of EGFR
    Jin Jia
    Wang Leiping
    Tao Zhonghua
    Zhang Jian
    Lv Fangfang
    Cao Junning
    Hu Xichun
    MOLECULAR MEDICINE REPORTS, 2020, 21 (05) : 2209 - 2219
  • [36] Activation of unfolded protein response overcomes Ibrutinib resistance in diffuse large B-cell lymphoma
    Xiao-tuan Zhang
    Xiao-bei Hu
    Han-lin Wang
    Wei-juan Kan
    Lei Xu
    Zhi-jia Wang
    Yu-qi Xiang
    Wen-biao Wu
    Bo Feng
    Jia-nan Li
    An-hui Gao
    Tian-cheng Dong
    Chun-mei Xia
    Yu-bo Zhou
    Jia Li
    Acta Pharmacologica Sinica, 2021, 42 : 814 - 823
  • [37] Lack of IKBA coding region mutations in primary mediastinal large B-cell lymphoma and the host response subtype of diffuse large B-cell lymphoma
    Takahashi, H
    Feuerhake, F
    Monti, S
    Kutok, JL
    Aster, JC
    Shipp, MA
    BLOOD, 2006, 107 (02) : 844 - 845
  • [38] The GCB subtype of diffuse large B-cell lymphoma is less frequent in Asian countries
    Shiozawa, Eisuke
    Yamochi-Onizuka, Toshiko
    Takimoto, Masafumi
    Ota, Hidekazu
    LEUKEMIA RESEARCH, 2007, 31 (11) : 1579 - 1583
  • [39] PQR309, idelalisib, duvelisib and ibrutinib lead to similar gene expression changes in activated B-cell like (ABC) diffuse large B-cell lymphoma (DLBCL)
    Arribas, A.
    Rinaldi, A.
    Spriano, F.
    Tarantelli, C.
    Gaudio, E.
    Bernasconi, E.
    Hillmann, R.
    Kwee, I.
    Stathis, A.
    Fabbro, D.
    Stussi, G.
    Zucca, E.
    Rossi, D.
    Cmiljanovic, V.
    Bertoni, F.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S39 - S39
  • [40] Unclassifiable B-cell lymphoma: Between diffuse large B-cell lymphoma and Burkitt lymphoma
    Mandi, Y.
    Malihy, A.
    Kettani, F.
    Alaammari, I.
    Khmou, M.
    Touri, S.
    Rouas, L.
    Lamalmi, N.
    El Khorassani, M.
    Alhamany, Z.
    ARCHIVES DE PEDIATRIE, 2015, 22 (06): : 661 - 664
12345